← 返回

热点话题:癌症免疫治疗与 NK 细胞

英文原题:A Hot Topic: Cancer Immunotherapy and Natural Killer Cells.

查看英文原题

A Hot Topic: Cancer Immunotherapy and Natural Killer Cells.

PubMed 2022/01/12(内容时间) Int J Mol Sci Q1 · IF 5.6(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

尽管近年来取得了显著进展,但针对多种不同形式的人类癌症的治疗方法仍然常常是一项挑战。除了成熟的癌症手术、放疗和化疗外,免疫治疗策略越来越受到关注,其中一些已成功引入临床。在这些策略中,基于自然杀伤(NK)细胞的免疫治疗被认为是最有前景的选择之一。在本综述中,我们将阐述NK细胞在此背景下提供的不同可能性,比较有关理论背景和作用机制的数据,报告一些临床试验结果,并指出几个非常近期的趋势。制药行业对NK细胞免疫治疗相当感兴趣,这将有利于该领域进展的速度。

展开英文摘要原文

Despite significant progress in recent years, the therapeutic approach of the multiple different forms of human cancer often remains a challenge. Besides the well-established cancer surgery, radiotherapy and chemotherapy, immunotherapeutic strategies gain more and more attention, and some of them have already been successfully introduced into the clinic. Among these, immunotherapy based on natural killer (NK) cells is considered as one of the most promising options.

In the present review, we will expose the different possibilities NK cells offer in this context, compare data about the theoretical background and mechanism(s) of action, report some results of clinical trials and identify several very recent trends. The pharmaceutical industry is quite interested in NK cell immunotherapy, which will benefit the speed of progress in the field.

论文信息

作者
Michel T、Ollert M、Zimmer J
单位
Department of Infection and Immunity, Luxembourg Institute of Health, 29 Rue Henri Koch, L-4354 Esch-sur-Alzette, Luxembourg.Luxembourg
文献类型
综述
期刊
International journal of molecular sciences2022 Jan 12
原文标识
PubMed 35054985 · DOI 10.3390/ijms23020797